{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:30:05Z","timestamp":1784086205231,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Geraiss Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gicoCoordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08764-y","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:19:34Z","timestamp":1751444374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prenylated chalcone analog-mediated Inhibition of Toxoplasma gondii growth in human trophoblast cell line and villous explants"],"prefix":"10.1038","volume":"15","author":[{"given":"Marina","family":"Paschoalino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilson Serafim","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio Henrique Locateli","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Carvalho","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Monteiro","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Paulo Oliveira","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Pereira","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joed Pires","family":"De Lima J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Carine Lima","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Martins","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izadora Santos","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Vieira","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Carvalho","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thales Alves de Melo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosiane Nascimento","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Oliveira Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa Am\u00e1lia","family":"Vieira Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Cota","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Octavio","family":"Regasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bellisa Freitas","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"8764_CR1","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/s0031182012000765","volume":"139","author":"JP Dubey","year":"2012","unstructured":"Dubey, J. P., Lago, E. G., Gennari, S. M., Su, C. & Jones, J. L. Toxoplasmosis in humans and animals in brazil: High prevalence, high burden of disease, and epidemiology. Parasitology 139, 1375\u20131424. https:\/\/doi.org\/10.1017\/s0031182012000765 (2012).","journal-title":"Parasitology"},{"key":"8764_CR2","doi-asserted-by":"publisher","unstructured":"Montoya, J. G., Liesenfeld, O. & Toxoplasmosis Lancet 363, 1965\u2013 (1976). https:\/\/doi.org\/10.1016\/s0140-6736(04)16412-x (2004).","DOI":"10.1016\/s0140-6736(04)16412-x"},{"key":"8764_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejogrb.2020.10.003","volume":"255","author":"M Ahmed","year":"2020","unstructured":"Ahmed, M., Sood, A. & Gupta, J. Toxoplasmosis in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 255, 44\u201350. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.003 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"8764_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/01.inf.0000115949.12206.69","volume":"23","author":"L Kodjikian","year":"2004","unstructured":"Kodjikian, L. et al. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr. Infect. Dis. J. 23, 272\u2013274. https:\/\/doi.org\/10.1097\/01.inf.0000115949.12206.69 (2004).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"8764_CR5","doi-asserted-by":"publisher","first-page":"e97775","DOI":"10.1371\/journal.pone.0097775","volume":"9","author":"XL Li","year":"2014","unstructured":"Li, X. L., Wei, H. X., Zhang, H., Peng, H. J. & Lindsay, D. S. A Meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One. 9, e97775. https:\/\/doi.org\/10.1371\/journal.pone.0097775 (2014).","journal-title":"PLoS One"},{"key":"8764_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1586\/eri.12.58","volume":"10","author":"PA Moncada","year":"2012","unstructured":"Moncada, P. A. & Montoya, J. G. Toxoplasmosis in the fetus and newborn: An update on prevalence, diagnosis and treatment. Expert Rev. Anti Infect. Ther. 10, 815\u2013828. https:\/\/doi.org\/10.1586\/eri.12.58 (2012).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"8764_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya, J. G. & Remington, J. S. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 47, 554\u2013566. https:\/\/doi.org\/10.1086\/590149 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"8764_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","volume":"17","author":"RR Ben-Harari","year":"2017","unstructured":"Ben-Harari, R. R., Goodwin, E. & Casoy, J. Adverse event profile of Pyrimethamine-Based therapy in toxoplasmosis: A systematic review. Drugs R D  17, 523\u2013544. https:\/\/doi.org\/10.1007\/s40268-017-0206-8 (2017).","journal-title":"Drugs R D"},{"key":"8764_CR9","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1086\/340577","volume":"185","author":"TV Aspinall","year":"2002","unstructured":"Aspinall, T. V., Joynson, D. H. M., Guy, E., Hyde, J. E. & Sims, P. F. G. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J. Infect. Dis. 185, 1637\u20131643. https:\/\/doi.org\/10.1086\/340577 (2002).","journal-title":"J. Infect. Dis."},{"key":"8764_CR10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","volume":"9","author":"M Montazeri","year":"2018","unstructured":"Montazeri, M. et al. Drug resistance in Toxoplasma gondii. Front. Microbiol. 9, 2587. https:\/\/doi.org\/10.3389\/fmicb.2018.02587 (2018).","journal-title":"Front. Microbiol."},{"key":"8764_CR11","doi-asserted-by":"publisher","first-page":"e0170689","DOI":"10.1371\/journal.pone.0170689","volume":"12","author":"LA Silva","year":"2017","unstructured":"Silva, L. A., Reis-Cunha, J. L., Bartholomeu, D. C. & V\u00edtor, R. W. A. Genetic polymorphisms and phenotypic profiles of sulfadiazine-resistant and sensitive Toxoplasma gondii isolates obtained from newborns with congenital toxoplasmosis in Minas gerais, Brazil. PLoS One. 12, e0170689. https:\/\/doi.org\/10.1371\/journal.pone.0170689 (2017).","journal-title":"PLoS One"},{"key":"8764_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/mmbr.64.3.607-623.2000","volume":"64","author":"MW Black","year":"2000","unstructured":"Black, M. W. & Boothroyd, J. C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 64, 607\u2013623. https:\/\/doi.org\/10.1128\/mmbr.64.3.607-623.2000 (2000).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"8764_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/a-1148-9000","volume":"86","author":"L Mamede","year":"2020","unstructured":"Mamede, L., Ledoux, A., Jansen, O. & Fr\u00e9d\u00e9rich, M. Natural phenolic compounds and derivatives as potential antimalarial agents. Planta Med. 86, 585\u2013618. https:\/\/doi.org\/10.1055\/a-1148-9000 (2020).","journal-title":"Planta Med."},{"key":"8764_CR14","doi-asserted-by":"publisher","first-page":"e2100310","DOI":"10.1002\/cbdv.202100310","volume":"18","author":"LA Lucas","year":"2021","unstructured":"Lucas, L. A. et al. Antiparasitic properties of Propolis extracts and their compounds. Chem. Biodivers. 18, e2100310. https:\/\/doi.org\/10.1002\/cbdv.202100310 (2021).","journal-title":"Chem. Biodivers."},{"key":"8764_CR15","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.2174\/1389557522666220404090429","volume":"22","author":"J Soto-S\u00e1nchez","year":"2022","unstructured":"Soto-S\u00e1nchez, J. Bioactivity of natural polyphenols as antiparasitic agents and their biochemical targets. Mini Rev. Med. Chem. 22, 2661\u20132677. https:\/\/doi.org\/10.2174\/1389557522666220404090429 (2022).","journal-title":"Mini Rev. Med. Chem."},{"key":"8764_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1568026620666201022143236","volume":"21","author":"J Xiao","year":"2021","unstructured":"Xiao, J., Gao, M., Diao, Q. & Gao, F. Chalcone derivatives and their activities against drug-resistant cancers: An overview. Curr. Top. Med. Chem. 21, 348\u2013362. https:\/\/doi.org\/10.2174\/1568026620666201022143236 (2021).","journal-title":"Curr. Top. Med. Chem."},{"key":"8764_CR17","doi-asserted-by":"publisher","first-page":"S2890","DOI":"10.1016\/j.arabjc.2013.11.018","volume":"10","author":"SA Khan","year":"2017","unstructured":"Khan, S. A. & Asiri, A. M. Green synthesis, characterization and biological evaluation of novel chalcones as anti-bacterial agents. Arab. J. Chem. 10, S2890\u2013S2895. https:\/\/doi.org\/10.1016\/j.arabjc.2013.11.018 (2017).","journal-title":"Arab. J. Chem."},{"key":"8764_CR18","doi-asserted-by":"publisher","first-page":"103133","DOI":"10.1016\/j.bioorg.2019.103133","volume":"91","author":"M Xu","year":"2019","unstructured":"Xu, M., Wu, P., Shen, F., Ji, J. & Rakesh, K. P. Chalcone derivatives and their antibacterial activities: Current development. Bioorg. Chem. 91, 103133. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103133 (2019).","journal-title":"Bioorg. Chem."},{"key":"8764_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4155\/fmc-2022-0013","volume":"14","author":"AS de Oliveira","year":"2022","unstructured":"de Oliveira, A. S. et al. Novel trypanocidal thiophen-chalcone cruzain inhibitors: Structure- and ligand-based studies. Future Med. Chem. 14, 795\u2013808. https:\/\/doi.org\/10.4155\/fmc-2022-0013 (2022).","journal-title":"Future Med. Chem."},{"key":"8764_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00436-018-6164-4","volume":"118","author":"MR Trein","year":"2019","unstructured":"Trein, M. R. et al. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues. Parasitol. Res. 118, 607\u2013615. https:\/\/doi.org\/10.1007\/s00436-018-6164-4 (2019).","journal-title":"Parasitol. Res."},{"key":"8764_CR21","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.3390\/molecules26237177","volume":"26","author":"M Rudrapal","year":"2021","unstructured":"Rudrapal, M. et al. Chalcone scaffolds, bioprecursors of flavonoids: Chemistry, bioactivities, and pharmacokinetics. Molecules 26, 7177. https:\/\/doi.org\/10.3390\/molecules26237177 (2021).","journal-title":"Molecules"},{"key":"8764_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1517\/13543776.14.12.1669","volume":"14","author":"L Ni","year":"2004","unstructured":"Ni, L., Meng, C. Q. & Sikorski, J. A. Recent advances in therapeutic chalcones. Expert Opin. Ther. Pat. 14, 1669\u20131691. https:\/\/doi.org\/10.1517\/13543776.14.12.1669 (2004).","journal-title":"Expert Opin. Ther. Pat."},{"key":"8764_CR23","doi-asserted-by":"publisher","first-page":"106888","DOI":"10.1016\/j.bioorg.2023.106888","volume":"141","author":"LR Oliveira","year":"2023","unstructured":"Oliveira, L. R. et al. Phenolic chalcones as agents against Trichomonas vaginalis. Bioorg. Chem. 141, 106888. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106888 (2023).","journal-title":"Bioorg. Chem."},{"key":"8764_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens10020175","volume":"10","author":"AM Zheoat","year":"2021","unstructured":"Zheoat, A. M. et al. Antitrypanosomal and antileishmanial activity of Chalcones and flavanones from Polygonum salicifolium. Pathogens 10, 1\u20139. https:\/\/doi.org\/10.3390\/pathogens10020175 (2021).","journal-title":"Pathogens"},{"key":"8764_CR25","doi-asserted-by":"publisher","unstructured":"Cuellar, J. E., Qui\u00f1ones, W., Robledo, S., Gil, J. & Durango, D. Coumaro-chalcones synthesized under solvent-free conditions as potential agents against malaria, leishmania and trypanosomiasis. Heliyon 8, e08939. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e08939 (2022).","DOI":"10.1016\/j.heliyon.2022.e08939"},{"key":"8764_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ejmech.2019.02.028","volume":"167","author":"JC Espinoza-Hicks","year":"2019","unstructured":"Espinoza-Hicks, J. C. et al. Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation. Eur. J. Med. Chem. 167, 402\u2013413. https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.028 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"8764_CR27","doi-asserted-by":"publisher","first-page":"e2000157","DOI":"10.1002\/ardp.202000157","volume":"353","author":"LA Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez, L. A. et al. Effect of substituents in the A and B rings of chalcones on antiparasite activity. Arch. Pharm. (Weinheim) 353, e2000157. https:\/\/doi.org\/10.1002\/ardp.202000157 (2020).","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"8764_CR28","doi-asserted-by":"publisher","first-page":"106129","DOI":"10.1016\/j.micpath.2023.106129","volume":"180","author":"ATL dos Santos","year":"2023","unstructured":"dos Santos, A. T. L. et al. Synthesis of Chalcones and their antimicrobial and drug potentiating activities. Microb. Pathog. 180, 106129. https:\/\/doi.org\/10.1016\/j.micpath.2023.106129 (2023).","journal-title":"Microb. Pathog"},{"key":"8764_CR29","doi-asserted-by":"publisher","unstructured":"Satokata, A. A. C. et al. Chalcones With potential antibacterial and antibiofilm activities against periodontopathogenic bacteria. Anaerobe 76, 102588. https:\/\/doi.org\/10.1016\/j.anaerobe.2022.102588 (2022).","DOI":"10.1016\/j.anaerobe.2022.102588"},{"key":"8764_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijpddr.2018.02.006","volume":"8","author":"H Si","year":"2018","unstructured":"Si, H. et al. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo. Int. J. Parasitol. Drugs Drug Resist. 8, 238\u2013245. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.02.006 (2018).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"8764_CR31","doi-asserted-by":"publisher","first-page":"114244","DOI":"10.1016\/j.ejmech.2022.114244","volume":"234","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. Discovery and evaluation of chalcone derivatives as novel potential anti-Toxoplasma gondii agents. Eur. J. Med. Chem. 234, 114244. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114244 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"8764_CR32","doi-asserted-by":"publisher","first-page":"1113896","DOI":"10.3389\/fcimb.2023.1113896","volume":"13","author":"AFF Mart\u00ednez","year":"2023","unstructured":"Mart\u00ednez, A. F. F. et al. Leaf hydroalcoholic extract and oleoresin from Copaifera multijuga control Toxoplasma gondii infection in human trophoblast cells and placental explants from third-trimester pregnancy. Front. Cell. Infect. Microbiol. 13, 1113896. https:\/\/doi.org\/10.3389\/fcimb.2023.1113896 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"8764_CR33","doi-asserted-by":"publisher","first-page":"105123","DOI":"10.1016\/j.micinf.2023.105123","volume":"25","author":"M de Fernandes","year":"2023","unstructured":"de Fernandes, M. BjussuLAAO-II, an L-amino acid oxidase from Bothrops jararacussu snake venom, impairs Toxoplasma gondii infection in human trophoblast cells and villous explants from the third trimester of pregnancy. Microbes Infect. 25, 105123. https:\/\/doi.org\/10.1016\/j.micinf.2023.105123 (2023).","journal-title":"Microbes Infect."},{"key":"8764_CR34","doi-asserted-by":"publisher","first-page":"15158","DOI":"10.1038\/s41598-020-72230-0","volume":"10","author":"SC Teixeira","year":"2020","unstructured":"Teixeira, S. C. et al. Copaifera spp. oleoresins impair Toxoplasma gondii infection in both human trophoblastic cells and human placental explants. Sci. Rep. 10, 15158. https:\/\/doi.org\/10.1038\/s41598-020-72230-0 (2020).","journal-title":"Sci. Rep."},{"key":"8764_CR35","doi-asserted-by":"publisher","first-page":"108534","DOI":"10.1016\/j.exppara.2023.108534","volume":"250","author":"SC Teixeira","year":"2023","unstructured":"Teixeira, S. C. et al. Polyalthic acid and oleoresin from Copaifera trapezifolia Hayne reduce Toxoplasma gondii growth in human villous explants, even triggering an anti-inflammatory profile. Exp. Parasitol. 250, 108534. https:\/\/doi.org\/10.1016\/j.exppara.2023.108534 (2023).","journal-title":"Exp. Parasitol."},{"key":"8764_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1095\/biolreprod.114.124115","volume":"92","author":"BF Barbosa","year":"2015","unstructured":"Barbosa, B. F. et al. IL10, TGF beta1, and IFN gamma modulate intracellular signaling pathways and cytokine production to control Toxoplasma gondii infection in bewo trophoblast cells. Biol. Reprod. 92, 82. https:\/\/doi.org\/10.1095\/biolreprod.114.124115 (2015).","journal-title":"Biol. Reprod."},{"key":"8764_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.placenta.2005.06.006","volume":"27","author":"JG Oliveira","year":"2006","unstructured":"Oliveira, J. G. et al. BeWo trophoblasts are unable to control replication of Toxoplasma gondii, even in the presence of exogenous IFN-\u03b3. Placenta 27, 691\u2013698. https:\/\/doi.org\/10.1016\/j.placenta.2005.06.006 (2006).","journal-title":"Placenta"},{"key":"8764_CR38","doi-asserted-by":"publisher","first-page":"1243480","DOI":"10.3389\/fimmu.2023.1243480","volume":"14","author":"G de Souza","year":"2023","unstructured":"de Souza, G. et al. Trypanosoma Cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human Maternal\u2013Fetal interface. Front. Immunol. 14, 1243480. https:\/\/doi.org\/10.3389\/fimmu.2023.1243480 (2023).","journal-title":"Front. Immunol."},{"key":"8764_CR39","doi-asserted-by":"publisher","first-page":"110716","DOI":"10.1016\/j.cbi.2023.110716","volume":"384","author":"SC Teixeira","year":"2023","unstructured":"Teixeira, S. C. et al. Rottlerin impairs early and late steps of Toxoplasma gondii infection in human trophoblast cells and villous explants. Chem. Biol. Interact. 384, 110716. https:\/\/doi.org\/10.1016\/j.cbi.2023.110716 (2023).","journal-title":"Chem. Biol. Interact."},{"key":"8764_CR40","doi-asserted-by":"publisher","first-page":"101907","DOI":"10.1016\/j.tice.2022.101907","volume":"78","author":"AM Rosini","year":"2022","unstructured":"Rosini, A. M. et al. LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (Bewo) and human villous explants in a dependent-manner of TRIF, Myd88, NF-\u039ab and cytokines. Tissue Cell. 78, 101907. https:\/\/doi.org\/10.1016\/j.tice.2022.101907 (2022).","journal-title":"Tissue Cell."},{"key":"8764_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2017.00340","volume":"7","author":"RJ da Silva","year":"2017","unstructured":"da Silva, R. J. et al. Enrofloxacin and toltrazuril are able to reduce Toxoplasma gondii growth in human bewo trophoblastic cells and villous explants from human third trimester pregnancy. Front. Cell. Infect. Microbiol. 7, 340. https:\/\/doi.org\/10.3389\/fcimb.2017.00340 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"8764_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cbin.11222","volume":"44","author":"TE de Ara\u00fajo","year":"2020","unstructured":"de Ara\u00fajo, T. E. et al. Experimental models of maternal-fetal interface and their potential use for nanotechnology applications. Cell. Biol. Int. 44, 36\u201350. https:\/\/doi.org\/10.1002\/cbin.11222 (2020).","journal-title":"Cell. Biol. Int."},{"key":"8764_CR43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0020-7519(98)00076-9","volume":"28","author":"JF Dubremetz","year":"1998","unstructured":"Dubremetz, J. F., Garcia-R\u00e9guet, N., Conseil, V. & Fourmaux, M. N. Invited review apical organelles and host-cell invasion by apicomplexa. Int. J. Parasitol. 28, 1007\u20131013. https:\/\/doi.org\/10.1016\/S0020-7519(98)00076-9 (1998).","journal-title":"Int. J. Parasitol."},{"key":"8764_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fmicb.2019.00899","volume":"10","author":"W Zhu","year":"2019","unstructured":"Zhu, W., Li, J., Pappoe, F., Shen, J. & Yu, L. Strategies developed by Toxoplasma gondii to survive in the host. Front. Microbiol. 10, 899. https:\/\/doi.org\/10.3389\/fmicb.2019.00899 (2019).","journal-title":"Front. Microbiol."},{"key":"8764_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrmicro2858","volume":"10","author":"CA Hunter","year":"2012","unstructured":"Hunter, C. A. & Sibley, L. D. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10, 766\u2013778. https:\/\/doi.org\/10.1038\/nrmicro2858 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"8764_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.exppara.2015.11.005","volume":"160","author":"TFP de Mello","year":"2016","unstructured":"de Mello, T. F. P. et al. Ultrastructural and morphological changes in Leishmania (Viannia) Braziliensis treated with synthetic chalcones. Exp. Parasitol. 160, 23\u201330. https:\/\/doi.org\/10.1016\/j.exppara.2015.11.005 (2016).","journal-title":"Exp. Parasitol."},{"key":"8764_CR47","doi-asserted-by":"publisher","first-page":"105407","DOI":"10.1016\/j.ejps.2020.105407","volume":"151","author":"L Alonso","year":"2020","unstructured":"Alonso, L. et al. Antileishmanial activity of the chalcone derivative LQFM064 associated with reduced fluidity in the parasite membrane as assessed by EPR spectroscopy. Eur. J. Pharm. Sci. 151, 105407. https:\/\/doi.org\/10.1016\/j.ejps.2020.105407 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"8764_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1365-2958.2003.03823.x","volume":"51","author":"LY Kwok","year":"2004","unstructured":"Kwok, L. Y., Schl\u00fcter, D., Clayton, C. & Soldati, D. The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol. Microbiol. 51, 47\u201361. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03823.x (2004).","journal-title":"Mol. Microbiol."},{"key":"8764_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.placenta.2013.12.013","volume":"35","author":"BF Barbosa","year":"2014","unstructured":"Barbosa, B. F. et al. Susceptibility to Toxoplasma gondii proliferation in bewo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1\/2 phosphorylation and prostaglandin E2 production. Placenta 35, 152\u2013162. https:\/\/doi.org\/10.1016\/j.placenta.2013.12.013 (2014).","journal-title":"Placenta"},{"key":"8764_CR50","doi-asserted-by":"publisher","first-page":"12709","DOI":"10.1038\/s41598-021-92120-3","volume":"11","author":"G de Souza","year":"2021","unstructured":"de Souza, G. et al. Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants. Sci. Rep. 11, 12709. https:\/\/doi.org\/10.1038\/s41598-021-92120-3 (2021).","journal-title":"Sci. Rep."},{"key":"8764_CR51","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/fmicb.2019.00852","volume":"10","author":"ICB Milian","year":"2019","unstructured":"Milian, I. C. B. et al. Increased Toxoplasma gondii intracellular proliferation in human extravillous trophoblast cells (HTR8\/Svneo line) is sequentially triggered by MIF, ERK1\/2, and COX-2. Front. Microbiol. 10, 852. https:\/\/doi.org\/10.3389\/fmicb.2019.00852 (2019).","journal-title":"Front. Microbiol."},{"key":"8764_CR52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1479-5876-12-132","volume":"12","author":"LS Castro-Filice","year":"2014","unstructured":"Castro-Filice, L. S. et al. Azithromycin is able to control Toxoplasma gondii infection in human villous explants. J. Transl Med. 12, 132. https:\/\/doi.org\/10.1186\/1479-5876-12-132 (2014).","journal-title":"J. Transl Med."},{"key":"8764_CR53","doi-asserted-by":"publisher","first-page":"12733","DOI":"10.1074\/jbc.m112.419911","volume":"288","author":"C Sommerville","year":"2013","unstructured":"Sommerville, C. et al. Biochemical and immunological characterization of Toxoplasma gondii macrophage migration inhibitory factor. J. Biol. Chem. 288, 12733\u201312741. https:\/\/doi.org\/10.1074\/jbc.m112.419911 (2013).","journal-title":"J. Biol. Chem."},{"key":"8764_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/pim.12163","volume":"37","author":"KS Harker","year":"2015","unstructured":"Harker, K. S., Ueno, N. & Lodoen, M. B. Toxoplasma gondii dissemination: A parasite\u2019s journey through the infected host. Parasite Immunol. 37, 141\u2013149. https:\/\/doi.org\/10.1111\/pim.12163 (2015).","journal-title":"Parasite Immunol."},{"key":"8764_CR55","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3389\/fimmu.2019.01995","volume":"10","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S., Jiang, N., Farr, L., Ngobeni, R. & Moonah, S. Parasite-produced MIF cytokine: Role in immune evasion, invasion, and pathogenesis. Front. Immunol. 10, 1995. https:\/\/doi.org\/10.3389\/fimmu.2019.01995 (2019).","journal-title":"Front. Immunol."},{"key":"8764_CR56","first-page":"34","volume":"4","author":"MR Nejad","year":"2011","unstructured":"Nejad, M. R. et al. The evaluation of interleukin-8 chemokine in chronic and acute Toxoplasma gondii infection. Gastroenterol. Hepatol. Bed Bench. 4, 34\u201337 (2011).","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"8764_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fmicb.2019.00225","volume":"10","author":"ACA Pereira","year":"2019","unstructured":"Pereira, A. C. A. et al. Cyclooxygenase (COX)-2 inhibitors reduce Toxoplasma gondii infection and upregulate the pro-inflammatory immune response in Calomys callosus rodents and human monocyte cell line. Front. Microbiol. 10, 225. https:\/\/doi.org\/10.3389\/fmicb.2019.00225 (2019).","journal-title":"Front. Microbiol."},{"key":"8764_CR58","first-page":"33","volume":"69","author":"HR Chang","year":"1990","unstructured":"Chang, H. R., Grau, G. E. & Pech\u00e8re, J. C. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology 69, 33\u201337 (1990).","journal-title":"Immunology"},{"key":"8764_CR59","doi-asserted-by":"publisher","first-page":"108311","DOI":"10.1016\/j.exppara.2022.108311","volume":"239","author":"N Atmaca","year":"2022","unstructured":"Atmaca, N. & Atmaca, H. T. The correlation of TNF alpha levels with acute phase proteins in acute Toxoplasma gondii infection in mice. Exp. Parasitol. 239, 108311. https:\/\/doi.org\/10.1016\/j.exppara.2022.108311 (2022).","journal-title":"Exp. Parasitol."},{"key":"8764_CR60","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/hypertensionaha.114.04781","volume":"65","author":"K Onda","year":"2015","unstructured":"Onda, K. et al. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2\/heme oxygenase-1 pathway, reduces soluble Fms-like tyrosine kinase-1, and quenches endothelial dysfunction: Potential therapeutic for preeclampsia. Hypertension 65, 855\u2013862. https:\/\/doi.org\/10.1161\/hypertensionaha.114.04781 (2015).","journal-title":"Hypertension"},{"key":"8764_CR61","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/s0140-6736(10)60279-6","volume":"376","author":"EAP Steegers","year":"2010","unstructured":"Steegers, E. A. P., Von Dadelszen, P., Duvekot, J. J. & Pijnenborg, R. Pre-eclampsia. Lancet 376, 631\u2013644. https:\/\/doi.org\/10.1016\/s0140-6736(10)60279-6 (2010).","journal-title":"Lancet"},{"key":"8764_CR62","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1365-2249.2007.03583.x","volume":"151","author":"BF Barbosa","year":"2008","unstructured":"Barbosa, B. F., Silva, D. A. O., Costa, I. N., Mineo, J. R. & Ferro, E. A. V. BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by Interferon-gamma, interleukin-10 and transforming growth factor-\u03921. Clin. Exp. Immunol. 151, 536\u2013545. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03583.x (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"8764_CR63","doi-asserted-by":"publisher","unstructured":"Zeraik, M. L. et al. Identification of a prenyl chalcone as a competitive lipoxygenase inhibitor: Screening, biochemical evaluation and molecular modeling studies. Molecules 26, 2205. https:\/\/doi.org\/10.3390\/molecules26082205 (2021).","DOI":"10.3390\/molecules26082205"},{"key":"8764_CR64","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1016\/j.bmcl.2015.05.072","volume":"25","author":"TG Passalacqua","year":"2015","unstructured":"Passalacqua, T. G. et al. Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds. Bioorg. Med. Chem. Lett. 25, 3342\u20133345. https:\/\/doi.org\/10.1016\/j.bmcl.2015.05.072 (2015).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"8764_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4 (1983).","journal-title":"J. Immunol. Methods"},{"key":"8764_CR66","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s11686-022-00633-2","volume":"67","author":"ST Elazab","year":"2022","unstructured":"Elazab, S. T. & Arafa, F. M. Anti-Toxoplasma activities of some Egyptian plant extracts: An in vitro study. Acta Parasitol. 67, 1800\u20131806. https:\/\/doi.org\/10.1007\/s11686-022-00633-2 (2022).","journal-title":"Acta Parasitol."},{"key":"8764_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.vetpar.2011.11.008","volume":"186","author":"J de Portes","year":"2012","unstructured":"de Portes, J. A new type of pterocarpanquinone that affects Toxoplasma gondii tachyzoites in vitro. Vet. Parasitol. 186, 261\u2013269. https:\/\/doi.org\/10.1016\/j.vetpar.2011.11.008 (2012).","journal-title":"Vet. Parasitol."},{"key":"8764_CR68","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.biopha.2018.04.164","volume":"103","author":"D Kian","year":"2018","unstructured":"Kian, D. et al. Trypanocidal activity of copaiba oil and kaurenoic acid does not depend on macrophage killing machinery. Biomed. Pharmacother. 103, 1294\u20131301. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.164 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"8764_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2019.03.005","volume":"195","author":"MS Costa","year":"2019","unstructured":"Costa, M. S. et al. Increased ROS generation causes apoptosis-like death: Mechanistic insights into the Anti-Leishmania activity of a potent Ruthenium(II) complex. J. Inorg. Biochem. 195, 1\u201312. https:\/\/doi.org\/10.1016\/j.jinorgbio.2019.03.005 (2019).","journal-title":"J. Inorg. Biochem."},{"key":"8764_CR70","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1016\/j.ajpath.2011.02.005","volume":"178","author":"O De Gomes","year":"2011","unstructured":"De Gomes, O. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am. J. Pathol. 178, 2792\u20132801. https:\/\/doi.org\/10.1016\/j.ajpath.2011.02.005 (2011).","journal-title":"Am. J. Pathol."},{"key":"8764_CR71","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2174\/138920111795470976","volume":"12","author":"S Vaidya","year":"2011","unstructured":"Vaidya, S., Walsh, S. W., Gerk, M. & S. & Application of human placental villous tissue explants to study ABC transporter mediated efflux of 2,4-dinitrophenyl-S-glutathione. Curr. Pharm. Biotechnol. 12, 814\u2013823. https:\/\/doi.org\/10.2174\/138920111795470976 (2011).","journal-title":"Curr. Pharm. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08764-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08764-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08764-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:19:35Z","timestamp":1751444375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08764-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8764"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08764-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests and no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23539"}}